Bortezomib, Melphalan, Prednisone and Thalidomide (Vmpt)versus Bortezomib, Melphalan and Prednisone (Vmp) Inelderly Newly Diagnosed Myeloma Patients: A Prospective,randomized, Phase Iii Study

Palumbo, A.; Bringhen, S.; Rossi, D.; Ria, R.; Berretta, S.; Offidani, M.; Patriarca, F.; Nozzoli, C.; Levi, A.; Guglielmelli, T.; Benevolo, G.; Callea, V.; Liberati, A. M.; Crippa, C.; Di Renzo, N.; Catalano, L.; De Sabbata, G.; Rizzi, R.; Feo, C.; Mazza, R.; Farina, G.; Spadano, A.; Pisani, F.; Podda, L.; Aitoro, G.; Magarotto, V.; Astolfi, M.; Di Raimondo, F.; Gaidano, G.; Boccadoro, M.

Links

[hdl.handle.net]

Tools

Export citation

Search in Google Scholar

Bortezomib, Melphalan, Prednisone and Thalidomide (Vmpt)versus Bortezomib, Melphalan and Prednisone (Vmp) Inelderly Newly Diagnosed Myeloma Patients: A Prospective,randomized, Phase Iii Study

Proceedings article published in 2009 by A. Palumbo, S. Bringhen, D. Rossi, R. Ria, S. Berretta, M. Offidani, F. Patriarca, C. Nozzoli, A. Levi, T. Guglielmelli, G. Benevolo, V. Callea, A. M. Liberati, C. Crippa, N. Di Renzo and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload